Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
RESEARCH TOOLSreports
Clarity Pharmaceuticals Ltd. (CU6) Share Price & Analysis
37 Followers
CU6 Stock Chart & Stats
Day’s RangeAU$3.55 - AU$3.86
52-Week Range― - ―
Previous CloseAU$3.65
Volume144.78K
Average Volume (3M)N/A
Market Cap
AU$1.04B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Aug 21, 2024EPS Estimate
-AU$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.41Price Target Upside-11.43% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Clarity Pharmaceuticals Ltd. News
PremiumCompany Announcements
Clarity Pharmaceuticals Expands Market Offering
PremiumCompany Announcements
Clarity Pharmaceuticals Showcases Cancer Advances
PremiumCompany Announcements
Clarity Pharmaceuticals Director Adjusts Holdings
PremiumCompany Announcements
Clarity Pharmaceuticals Bolsters Finances and Trials
PremiumCompany Announcements
Clarity Pharmaceuticals Secures $121 Million Funding
PremiumCompany Announcements
Clarity Pharmaceuticals Announces Key Shareholder UpdatePremiumCompany Announcements
Clarity Pharmaceuticals Seeks New Securities Quotation
PremiumCompany Announcements
Clarity Pharmaceuticals Announces Ownership ShiftOptions Prices
Currently, No data available
---
Ownership Overview
1.33% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
98.67% Public Companies and
Individual Investors
CU6 FAQ
What was Clarity Pharmaceuticals Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Clarity Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is Clarity Pharmaceuticals Ltd.’s upcoming earnings report date?
Clarity Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 21, 2024 which is in 106 days.
How were Clarity Pharmaceuticals Ltd.’s earnings last quarter?
Clarity Pharmaceuticals Ltd. released its earnings results on Feb 29, 2024. The company reported -AU$0.066 earnings per share for the quarter, missing the consensus estimate of -AU$0.057 by -AU$0.009.
Is Clarity Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Clarity Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Clarity Pharmaceuticals Ltd. pay dividends?
Clarity Pharmaceuticals Ltd. does not currently pay dividends.
What is Clarity Pharmaceuticals Ltd.’s EPS estimate?
Clarity Pharmaceuticals Ltd.’s EPS estimate is -AU$0.05.
How many shares outstanding does Clarity Pharmaceuticals Ltd. have?
Currently, no data Available
What happened to Clarity Pharmaceuticals Ltd.’s price movement after its last earnings report?
Clarity Pharmaceuticals Ltd. reported an EPS of -AU$0.066 in its last earnings report, missing expectations of -AU$0.057. Following the earnings report the stock price went down -1.027%.
Which hedge fund is a major shareholder of Clarity Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:CU6
---
Clarity Pharmaceuticals Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$3.41 (-11.43% Downside)
AU$3.41 (-11.43% Downside)
Blogger Sentiment
Bullish
AU:CU6 Sentiment 98%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$86.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
388.62%
12-Months-Change
Fundamentals
Return on Equity
-45.33%
Trailing 12-Months
Asset Growth
-35.15%
Trailing 12-Months
Company Description
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
---
CU6 Stock 12 Months Forecast
Average Price Target
AU$3.41
▼(-11.43% Downside)
Technical Analysis
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
LBT Innovations Limited
―
Alcidion Group Limited
―
Micro-X Ltd.
―
Best Analysts Covering CU6
1 Year
1 Year Success Rate
11/11 ratings generated profit
1 Year Average Return
+184.79%
reiterated a buy rating 29 days ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +184.79% per trade.
---